Celldex Share Price

Celldex Share Price

NASDAQ: CLDX | Small Cap | Healthcare
$27.41
-$0.53 (-1.9%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Celldex Stock Performance

Open
$27.70
Prev. Close
$27.94
Circuit Range
N/A
Day Range
$26.78 - $28.39
Year Range
$22.37 - $45.07
Volume
1,55,327
Average Traded
$27.47

Celldex Share Price Today

As of 21 November 2026, Celldex Therapeutics, Inc.'s share price is $27.41. The stock opened at $27.70, compared to its previous close of $27.94. During today's trading session, Celldex Therapeutics, Inc.'s share price traded between $26.78 and $28.39, with an average price of $27.59. Over the past 52 weeks, the stock has recorded a high of $45.07 and a low of $22.37. In terms of performance, Celldex Therapeutics, Inc.'s share price has declined by 12.68% over the last six months and is up 1.48% on a year-on-year basis.

Celldex Share Price Chart

Line chart of the Celldex price trend over the selected period. The price fell overall, ranging from 26.79 to 28.39, ending at 27.38.
$26.78$28.39
L
Show Current Price
H

Celldex Stock Fundamentals & Key Indicators

Market Cap
$1.82B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.93
Revenue (TTM)
$1.55B
Return On Equity (TTM)
-47.59%
Profit Margin
-16694.19%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
7.08%

Celldex Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.12$0.02$0.02$0.00
Net Profit-$81.32-$78.69-$73.50-$75.56
Net Profit Margin-67766.67%-393450.00%-367500.00%N/A
Income ChangeN/A3.23%6.60%-2.80%

Celldex Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.36$6.88$7.02$1.55
Net Profit-$112.33-$141.43-$157.86-$258.76
Net Profit Margin-4759.75%-2055.67%-2248.72%-16694.19%
Income ChangeN/A-25.91%-11.62%-63.92%

Celldex Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets48.3245.1833.9335.04
Current Assets534.66747.16431.69317.69
Total Assets582.98792.34465.63352.74
Non Current Liabilities4.835.835.337.92
Current Liabilities50.9939.531.1318.61
Total Liabilities55.8245.3436.4626.53
Shareholders' Equity527.17747.01429.17326.2

Celldex Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-210.95-157.78-107.29-96.87
Investing209.07-290.13-105.7889.94
Financing2.39441.45218.46-2.79

Corporate Actions

Split
Ex-date: 11 Feb 2019

About Celldex

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Celldex Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$30.15
$27.43
-8.89%
Oct 2026
$32.16
$30.11
-7.41%
Sep 2026
$39.22
$32.52
-19.52%
Aug 2026
$37.93
$40.40
+6.12%
Jul 2026
$37.35
$38.07
+2.41%
Jun 2026
$30.95
$37.17
+18.43%
May 2026
$33.43
$31.39
-4.50%
Apr 2026
$32.12
$32.87
+3.67%
Mar 2026
$29.72
$31.70
+5.30%
Feb 2026
$24.59
$30.11
+22.25%
Jan 2026
$27.03
$24.63
-9.32%
Dec 2025
$26.48
$27.16
+0.56%

Celldex Share Price FAQs